Find information on medical topics, symptoms, drugs, procedures, news and more, written for the health care professional.

* This is the Professional Version. *

Immunologic Tests for Infectious Disease

by Kevin C. Hazen, PhD

Immunologic tests use an antigen to detect antibodies to a pathogen or use an antibody to detect an antigen of the pathogen in the patient’s specimen. Handling varies, but if testing is to be delayed, the specimen should typically be refrigerated or frozen to prevent overgrowth of bacterial contaminants.

Agglutination tests

In agglutination tests (eg, latex agglutination, coaggregation), a particle (latex bead or bacterium) is coupled to a reagent antigen or antibody. The resulting particle complex is mixed with the specimen (eg, CSF, serum); if the target antibody or antigen is present in the specimen, it cross-links the particles, producing measurable agglutination.

If results are positive, the body fluid is serially diluted and tested. Agglutination with more dilute solutions indicates higher concentrations of the target antigen or antibody. The titer is correctly reported as the reciprocal of the most dilute solution yielding agglutination; eg, 32 indicates that agglutination occurred in a solution diluted to 1/32 of the starting concentration.

Usually, agglutination tests are rapid but less sensitive than many other methods. They can also determine serotypes of some bacteria.

Complement fixation

This test measures complement-consuming (complement-fixing) antibody in serum or CSF. The test is used for diagnosis of some viral and fungal infections, particularly coccidioidomycosis. The specimen is incubated with known quantities of complement and the antigen that is the target of the antibody being measured. The degree of complement fixation indicates the relative quantity of the antibody in the specimen. The test can measure IgM and IgG antibody titers or can be modified to detect certain antigens. It is accurate but has limited applications, is labor intensive, and requires numerous controls.

Enzyme immunoassays

These tests use antibodies linked to enzymes to detect antigens and to detect and quantify antibodies. The enzyme immunoassay (EIA) and enzyme-linked immunosorbent assay (ELISA) are examples. Because sensitivities of most enzyme immunoassays are high, they are usually used for screening. Titers can be determined by serially diluting the specimen as for agglutination tests.

Test sensitivities, although usually high, can vary, sometimes according to patient age, microbial serotype, specimen type, or stage of clinical disease.

Precipitation tests

These tests measure an antigen or antibody in body fluids by the degree of visible precipitation of antigen-antibody complexes within a gel (agarose) or in solution. There are many types of precipitation tests (eg, Ouchterlony double diffusion, counterimmunoelectrophoresis), but their applications are limited. Usually, a blood specimen is mixed with test antigen to detect patient antibodies, most often in suspected fungal infection or pyogenic meningitis. Because a positive result requires a large amount of antibody or antigen, sensitivity is low.

Western blot test

This test detects antimicrobial antibodies in the patient’s sample (eg, serum, other body fluid) by their reaction with target antigens (eg, viral components) that have been immobilized onto a membrane by blotting.

The Western blot typically has good sensitivity, although often less than that of screening tests such as ELISA, but generally is highly specific. Thus, it is usually used to confirm a positive result obtained with a screening test.

Technical modifications of the Western blot are the line immunoassay (LIA); the recombinant immunoblot assay (RIBA), which uses synthetic or recombinant-produced antigens; and immunochromatographic assays, which can rapidly screen specimens for specific microbial antigens or patient antibodies. Of the three, the immunochromatographic assay is easiest to do and the most commonly used—eg, to detect Shiga toxin–producing microorganisms, Cryptococcus neoformans capsular antigen, and influenza virus.

* This is a professional Version *